Table 3 Distribution of VDR genotypes and alleles between prostate cancer cases and controls

FokI

FF

33 (0.270)

38 (0.292)

1.00(referent)

Ff

63 (0.517)

55 (0.423)

1.317(0.730-2.376)

0.361

ff

26 (0.213)

37 (0.285)

0.815(0.411-1.620)

0.560

F

129 (0.529)

131 (0.504)

1.00(referent)

f

115 (0.471)

129 (0.496)

0.910(0.641-1.291)

0.597

BsmI

bb

114 (0.934)

108 (0.831)

1.00(referent)

Bb

8 (0.066)

21 (0.162)

0.362(0.154-0.853)

0.020

BB *

0 (0)

1 (0.008)

-

-

b

236 (0.964)

237 (0.912)

1.00(referent)

B

8 (0.036)

23 (0.088)

0.351(0.154-0.800)

0.013

Tru9I

UU

76 (0.623)

78 (0.600)

1.00(referent)

Uu

41 (0.336)

47 (0.362)

0.902(0.533-1.525)

0.699

uu

5 (0.041)

5 (0.038)

1.039(0.289-3.742)

0.953

U

193 (0.791)

203 (0.781)

1.00(referent)

u

51 (0.209)

57 (0.219)

0.947(0.618-1.452)

0.804

ApaI

AA

10 (0.082)

9 (0.069)

1.00(referent)

Aa

56 (0.459)

61 (0.469)

0.800(0.300-2.128)

0.654

aa

56 (0.459)

60 (0.462)

0.810(0.304-2.160)

0.673

A

76 (0.311)

79 (0.304)

1.00(referent)

a

168 (0.689)

181 (0.696)

0.956(0.654-1.397)

0.814

TaqI

TT

112 (0.918)

121 (0.931)

1.00(referent)

Tt

10 (0.082)

9 (0.069)

1.213(0.475-3.098)

0.687

tt

0 (0)

0 (0)

-

-

T

234 (0.959)

251 (0.965)

1.00(referent)

t

10 (0.041)

9 (0.035)

1.204(0.480-3.016)

0.693